Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNo substantive changes to the trial's record history were observed between the old and new screenshots; the version list and study data appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check40 days agoChange DetectedMajor update: announces a funding-related operating status notice and a new version v3.2.0; replaces the earlier v3.1.0 release.SummaryDifference11%

- Check48 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

- Check55 days agoChange DetectedNew date and a new Study Status Contacts/Locations entry added; an older timestamp removed, indicating updated contact/location information and status details.SummaryDifference1%

- Check62 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.6%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.6%

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.